JPMorgan raised the firm’s price target on CME Group (CME) to $252 from $246 and keeps an Underweight rating on the shares. The firm says the company’s energy trading activity slowed in Q3 on lower volatility.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CME:
- Citi upgrades CME Group to Buy on near-term catalysts
- CME Group upgraded to Buy from Neutral at Citi
- Crypto Currents: Bullish secures New York BitLicense from NYDFS
- CME Group price target lowered to $285 from $305 at UBS
- CME Group reports August ADV of 28.1M contracts
